US Stock MarketDetailed Quotes

IQMDW INTELLIGENT MEDICINE ACQ CORP C/WTS (TO PUR COM)

Watchlist
  • 0.0025
  • 0.00000.00%
Trading Apr 26 16:00 ET
0Market Cap0.00P/E (TTM)

INTELLIGENT MEDICINE ACQ CORP C/WTS (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-866.9K
-451.69K
-94.78K
-134.22K
-186.21K
Net income from continuing operations
--11.41M
--2.83M
--1.24M
--2.97M
--4.37M
Operating gains losses
---13.26M
---3.44M
---1.78M
---3.38M
---4.66M
Other non cash items
---1
----
----
----
----
Change In working capital
--979.72K
--149.87K
--441.05K
--279.19K
--109.61K
-Change in prepaid assets
--20.55K
--9.38K
--22.54K
--21.85K
---33.21K
-Change in payables and accrued expense
--855.2K
--126.42K
--386.68K
--226.21K
--115.9K
-Change in other current assets
--103.97K
--14.07K
--31.83K
--31.14K
--26.93K
Cash from discontinued investing activities
Operating cash flow
---866.9K
---451.69K
---94.78K
---134.22K
---186.21K
Investing cash flow
Cash flow from continuing investing activities
341.15K
Net other investing changes
--341.15K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--341.15K
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
-13.37K
0
0
-13.37K
0
Net issuance payments of debt
--0
--0
--0
----
----
Net common stock issuance
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
----
----
Net other financing activities
---13.37K
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
---13.37K
--0
--0
---13.37K
--0
Net cash flow
Beginning cash position
--589.28K
--160.7K
--255.47K
--403.06K
--589.28K
Current changes in cash
---539.12K
---110.55K
---94.78K
---147.59K
---186.21K
End cash Position
--50.15K
--50.15K
--160.7K
--255.47K
--403.06K
Free cash flow
---866.9K
---451.69K
---94.78K
---134.22K
---186.21K
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -866.9K-451.69K-94.78K-134.22K-186.21K
Net income from continuing operations --11.41M--2.83M--1.24M--2.97M--4.37M
Operating gains losses ---13.26M---3.44M---1.78M---3.38M---4.66M
Other non cash items ---1----------------
Change In working capital --979.72K--149.87K--441.05K--279.19K--109.61K
-Change in prepaid assets --20.55K--9.38K--22.54K--21.85K---33.21K
-Change in payables and accrued expense --855.2K--126.42K--386.68K--226.21K--115.9K
-Change in other current assets --103.97K--14.07K--31.83K--31.14K--26.93K
Cash from discontinued investing activities
Operating cash flow ---866.9K---451.69K---94.78K---134.22K---186.21K
Investing cash flow
Cash flow from continuing investing activities 341.15K
Net other investing changes --341.15K----------------
Cash from discontinued investing activities
Investing cash flow --341.15K----------------
Financing cash flow
Cash flow from continuing financing activities -13.37K00-13.37K0
Net issuance payments of debt --0--0--0--------
Net common stock issuance --0--0--0--0--0
Proceeds from stock option exercised by employees --0----------------
Net other financing activities ---13.37K--0--0--------
Cash from discontinued financing activities
Financing cash flow ---13.37K--0--0---13.37K--0
Net cash flow
Beginning cash position --589.28K--160.7K--255.47K--403.06K--589.28K
Current changes in cash ---539.12K---110.55K---94.78K---147.59K---186.21K
End cash Position --50.15K--50.15K--160.7K--255.47K--403.06K
Free cash flow ---866.9K---451.69K---94.78K---134.22K---186.21K
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg